Barbara Metch - Concepedia

Author

Barbara Metch

Cancer Research And Biostatistics

Also Known As

B Metch, B. Metch, BARBARA METCH, Barbara Metch, Barbara S. Metch

Publications

2.1K

Citations

H-Index

Concepts

All Affiliations

Cancer Research And Biostatistics SWOG Cancer Research Network The Ohio State University Wayne State University University of Puget Sound

About

Barbara Metch is an author at Cancer Research And Biostatistics specializing in oncology, cancer research, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	210
2	Health Sciences	4	4	166
3	Nursing	1	1	20
4	Public Health	1	1	20
5	Family Medicine	1	1	20

Barbara Metch

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study. Arlene A. Forastiere, Barbara Metch, Dorit Elisabeth Schuller, Journal of Clinical Oncology	1992	751
Preoperative chemotherapy in advanced resectable head and neck cancer: Final report of the southwest oncology group David E. Schuller, David W. Stem, Barbara Metch, The Laryngoscope	1988	268
Phase III Comparison of Doxorubicin and Dacarbazine Given by Bolus Versus Infusion in Patients With Soft-Tissue Sarcomas: A Southwest Oncology Group Study Mark M. Zalupski, Barbara Metch, S P Balcerzak, JNCI Journal of the National Cancer Institute	1991	170
Adjuvant CMFVP versus tamoxifen versus concurrent CMFVP and tamoxifen for postmenopausal, node-positive, and estrogen receptor-positive breast cancer patients: a Southwest Oncology Group study. Saul E. Rivkin, S Green, Barbara Metch, Journal of Clinical Oncology	1994	101
Platinum analogs in recurrent and advanced head and neck cancer: a Southwest Oncology Group and Wayne State University Study. Muhyi Al‐Sarraf, Barbara Metch, Julie A. Kish, PubMed Neck CancerPathologyPharmacotherapyCisplatin CombinationsOncology	1987	68
Phase II Studies of Recombinant Human Tumor Necrosis Factor Alpha in Patients with Malignant Disease: A Summary of the Southwest Oncology Group Experience Evan M. Hersh, Barbara Metch, Franco M. Muggia, Journal of Immunotherapy	1991	66
Phase II Evaluation of Recombinant Interferon-β (LFN-β <sub>ser</sub> ) in Patients with Diffuse Mesothelioma: A Southwest Oncology Group Study Daniel D. Von Hoff, Barbara Metch, Joel G. Lucas, Journal of Interferon Research	1990	47
A phase II evaluation of ifosfamide and mesna in unresectable diffuse malignant mesothelioma: A southwest oncology group study Bernard L. Zidar, Barbara Metch, Stanley P. Balcerzak, Cancer	1992	42
Adjuvant CMFVP versus melphalan for operable breast cancer with positive axillary nodes: 10-year results of a Southwest Oncology Group Study. Saul E. Rivkin, Stephanie Green, Barbara Metch, Journal of Clinical Oncology Surgical OncologyBreast OncologyCancer ManagementPathologyDisease-free Survival	1989	41
Analysis of Treatment Failure Patterns: A Southwest Oncology Group Study Dorit Elisabeth Schuller, Diana W. Stein, Barbara Metch Archives of Otolaryngology - Head and Neck Surgery Surgical OncologyCancer ManagementMetronomic ChemotherapyNeck OncologyRadiation Oncology	1989	40

Page 1